Low-dose metoclopramide-induced dystonia in cannabis withdrawal syndrome manifesting as intractable nausea and vomiting

BMJ Case Reports, Journal Year: 2025, Volume and Issue: 18(5), P. e264815 - e264815

Published: May 1, 2025

Cannabis withdrawal syndrome (CWS) presents with irritability, anxiety and sleep disturbances within a week of stopping cannabis use. This case highlights young woman medical history recurrent hospitalisations due to intractable nausea vomiting related heavy, prolonged use acute dystonic reactions secondary haloperidol. The patient presented nausea, frequent hot bathing five days after her last She developed an reaction low-dose metoclopramide, commonly used antiemetic, potentially exacerbated by cannabis’s inhibition drug-metabolising enzymes. We also highlight key differences between CWS hyperemesis (CHS).

Language: Английский

Reply

Gastroenterology, Journal Year: 2024, Volume and Issue: 167(5), P. 1056 - 1057

Published: June 29, 2024